The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.390
https://www.valueinhealthjournal.com/article/S1098-3015(17)30724-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
365
First Page :
A467
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30724-6&doi=10.1016/j.jval.2017.08.390